Literature DB >> 15651036

Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.

Stewart B Kirton1, Christopher W Murray, Marcel L Verdonk, Richard D Taylor.   

Abstract

The cytochromes P450 (P450s) are a family of heme-containing monooxygenase enzymes involved in a variety of functions, including the metabolism of endogenous and exogenous substances in the human body. During lead optimization, and in drug development, many potential drug candidates are rejected because of the affinity they display for drug-metabolising P450s. Recently, crystal structures of human enzymes involved in drug metabolism have been determined, significantly augmenting the prospect of using structure-based design to modulate the binding and metabolizing properties of compounds against P450 proteins. An important step in the application of structure-based metabolic optimization is the accurate prediction of docking modes in heme binding proteins. In this paper we assess the performance of the docking program GOLD at predicting the binding mode of 45 heme-containing complexes. We achieved success rates of 64% and 57% for Chemscore and Goldscore respectively; these success rates are significantly lower than the value of 79% observed with both scoring functions for the full GOLD validation set. Re-parameterization of metal-acceptor interactions and lipophilicity of planar nitrogen atoms in the scoring functions resulted in a significant increase in the percentage of successful dockings against the heme binding proteins (Chemscore 73%, Goldscore 65%). The modified scoring functions will be useful in docking applications on P450 enzymes and other heme binding proteins. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15651036     DOI: 10.1002/prot.20389

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  20 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Enhanced dynamics of HIV gp120 glycoprotein by small molecule binding.

Authors:  Indira Shrivastava; Judith M LaLonde
Journal:  Biochemistry       Date:  2011-04-21       Impact factor: 3.162

3.  O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1.

Authors:  William P Malachowski; Maria Winters; James B DuHadaway; Ariel Lewis-Ballester; Shorouk Badir; Jenny Wai; Maisha Rahman; Eesha Sheikh; Judith M LaLonde; Syun-Ru Yeh; George C Prendergast; Alexander J Muller
Journal:  Eur J Med Chem       Date:  2015-12-17       Impact factor: 6.514

Review 4.  Molecular docking: a powerful approach for structure-based drug discovery.

Authors:  Xuan-Yu Meng; Hong-Xing Zhang; Mihaly Mezei; Meng Cui
Journal:  Curr Comput Aided Drug Des       Date:  2011-06       Impact factor: 1.606

Review 5.  Interactions of cytochrome P450s with their ligands.

Authors:  Kip P Conner; Caleb M Woods; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2010-10-19       Impact factor: 4.013

6.  Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  ACS Med Chem Lett       Date:  2022-02-24       Impact factor: 4.345

7.  Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.

Authors:  Esther Jortzik; Kathleen Zocher; Antje Isernhagen; Boniface M Mailu; Stefan Rahlfs; Giampietro Viola; Sergio Wittlin; Nicholas H Hunt; Heiko Ihmels; Katja Becker
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

8.  Docking and scoring with ICM: the benchmarking results and strategies for improvement.

Authors:  Marco A C Neves; Maxim Totrov; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2012-05-09       Impact factor: 3.686

Review 9.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

10.  Homotropic Cooperativity of Midazolam Metabolism by Cytochrome P450 3A4: Insight from Computational Studies.

Authors:  Junhao Li; Yue Chen; Yun Tang; Weihua Li; Yaoquan Tu
Journal:  J Chem Inf Model       Date:  2021-04-22       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.